Atropine Sulfate Ophthalmic Solution, USP 1%, 5 mL bottles, Rx only, Manufactured for: Somerset Therapeutics, LLC. Somerset, NJ 08873, NDC 70069-716-01
Published January 8, 2025 · Recall initiated: December 16, 2024
Summary
FDA records drug Class III recall D-0169-2025, published January 8, 2025 and initiated December 16, 2024. Recalling firm: SOMERSET THERAPEUTICS LLC; Status: Terminated; Reported quantity: 5,870 bottles; Lot: Lot #: A240211, Exp. Date April 2026. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Impurities/Degradation Specifications
What to do
Voluntary: Firm initiated · Letter
Get an email if ATROPINE SULFATE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- ATROPINE SULFATE
- Manufacturer
- SOMERSET THERAPEUTICS LLC
- Distributor
- Nationwide within the United States
- UPC
- 0370069716014
- Lot
- Lot #: A240211, Exp. Date April 2026
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAAtropine Sulfate injection, USP, 1 mg/mL, For intravenous Use, Sterile, packaged in a) 1 mL Single-Dose VialAugust 26, 2026
- FDANitrofurantoin Capsules, USP, 100 mg, 50 Capsules (5 x 10) Unit Dose per carton, Rx Only, Manufactured for:January 8, 2025
- FDAFORCE FOREVER 400mg Tablets, Huesos y articulaciones sin dolor, SUPLEMENTO ALIMENTICIO, 60-count bottlesJanuary 8, 2025
- FDALevothyroxine Sodium Tablets, Lupin, 75 mcg (0.075mg), 1000 Tablets, Rx Only, Manufactured for: LupinJanuary 8, 2025
- FDAAtropine Sulfate Injection, USP 1 mg/10 mL (0.1 mg/mL), Lifeshield, Glass ABBOJECT Unit of Use Syringe, RxJanuary 24, 2024
- FDAAtropine Sulfate Injection, USP 8 mg per 20 mL (0.4 mg per mL), 20 mL Multiple Dose Vials, Rx only,July 19, 2023
Questions about this recall
Was Atropine Sulfate Ophthalmic Solution, USP 1%, 5 mL bottles, Rx only, Manufactured for: Somerset Therapeutics, LLC. Somerset, NJ 08873, NDC 70069-716-01 recalled?
Yes. FDA published recall D-0169-2025 on January 8, 2025. Reported hazard: Failed Impurities/Degradation Specifications
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: ATROPINE SULFATE. UPC: 0370069716014.